Jaykay Enterprises Subsidiary Neumesh Labs Receives MCA Investigation Notice
Jaykay Enterprises Limited informed stock exchanges about an investigation notice received by its subsidiary Neumesh Labs Private Limited from the Ministry of Corporate Affairs on April 30, 2026. The notice seeks information and documents for examination, with the company committing full cooperation and stating no specific violations have been alleged with no immediate material impact identified.

*this image is generated using AI for illustrative purposes only.
Jaykay Enterprises Limited has informed stock exchanges about an investigation notice received by its subsidiary from regulatory authorities. The disclosure was made on May 01, 2026, in compliance with SEBI listing regulations and follows an earlier intimation dated June 19, 2025.
Investigation Notice Details
Neumesh Labs Private Limited, a subsidiary of Jaykay Enterprises, received a notice of investigation from the Office of the Regional Director (Northern Region), Ministry of Corporate Affairs (MCA) on April 30, 2026. The notice seeks information and documents for examination purposes.
| Parameter: | Details |
|---|---|
| Authority: | Office of the Regional Director (Northern Region), MCA |
| Notice Received: | April 30, 2026 |
| Subsidiary Affected: | Neumesh Labs Private Limited |
| Nature of Action: | Investigation notice seeking documents for examination |
| Filing Date: | May 01, 2026 |
Company Response and Compliance
The company stated that Neumesh Labs will extend necessary cooperation to the authorities and is currently in the process of submitting the required information and documents sought by MCA. The disclosure was signed by Company Secretary and Compliance Officer Shikha Rastogi and communicated to both BSE Limited and National Stock Exchange of India Ltd.
Regulatory Filing Requirements
The disclosure was made pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also referenced SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 in its filing.
| Compliance Parameter: | Details |
|---|---|
| Regulation: | SEBI Listing Regulations 30 |
| BSE Scrip Code: | 500306 |
| NSE Symbol: | JAYKAY |
| Company Secretary: | Shikha Rastogi |
| Website Disclosure: | www.jaykayenterprises.com |
Impact Assessment
According to the disclosure, no specific violation or contravention has been stated in the communication received from MCA. The company has assessed that no immediate material impact has been identified on its financial, operational, or other activities as of the disclosure date.
| Assessment Category: | Status |
|---|---|
| Specific Violations Alleged: | None stated |
| Material Financial Impact: | No immediate impact identified |
| Operational Impact: | No immediate impact identified |
| Company Cooperation: | Full cooperation committed |
Historical Stock Returns for Jaykay Enterprises
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.59% | +11.04% | +42.82% | -14.03% | -14.03% | -14.03% |
What potential regulatory changes or compliance gaps might have triggered MCA's investigation into Neumesh Labs' operations?
How could this investigation affect Jaykay Enterprises' ability to secure future business partnerships or financing arrangements?
Will the MCA investigation prompt similar scrutiny of other subsidiaries within Jaykay Enterprises' portfolio?


































